These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 30320499

  • 1. Functional role of RRS1 in breast cancer cell proliferation.
    Song J, Ma Z, Hua Y, Xu J, Li N, Ju C, Hou L.
    J Cell Mol Med; 2018 Dec; 22(12):6304-6313. PubMed ID: 30320499
    [Abstract] [Full Text] [Related]

  • 2. The role of RRS1 in breast cancer cells metastasis and AEG-1/AKT/c-Myc signaling pathway.
    He J, Liu S, Luo S, Fu J, Liao Z, Song J, Guo J, Hua Y.
    Neoplasma; 2024 Aug; 71(4):347-358. PubMed ID: 39267538
    [Abstract] [Full Text] [Related]

  • 3. Genomic gain of RRS1 promotes hepatocellular carcinoma through reducing the RPL11-MDM2-p53 signaling.
    Cao P, Yang A, Li P, Xia X, Han Y, Zhou G, Wang R, Yang F, Li Y, Zhang Y, Cui Y, Ji H, Lu L, He F, Zhou G.
    Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34433556
    [Abstract] [Full Text] [Related]

  • 4. Effect of RRS1 gene knockdown on BT549 cell line proliferation and apoptosis in breast cancer.
    Hua YN, Song JL, Ma ZL, Wu L, Zhang Z, Zhang L, Li N, Cong SB, Hou L.
    Neoplasma; 2019 Jan 15; 66(1):28-32. PubMed ID: 30509086
    [Abstract] [Full Text] [Related]

  • 5. Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
    Gao C, Xiao G, Piersigilli A, Gou J, Ogunwobi O, Bargonetti J.
    Breast Cancer Res; 2019 Jan 14; 21(1):5. PubMed ID: 30642351
    [Abstract] [Full Text] [Related]

  • 6. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
    Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J.
    Breast Cancer Res; 2011 Jan 11; 13(1):R3. PubMed ID: 21223569
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. c-Myc induced the regulation of long non-coding RNA RHPN1-AS1 on breast cancer cell proliferation via inhibiting P53.
    Zhu P, Li Y, Li P, Zhang Y, Wang X.
    Mol Genet Genomics; 2019 Oct 11; 294(5):1219-1229. PubMed ID: 31089812
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
    Shen A, Chen Y, Liu L, Huang Y, Chen H, Qi F, Lin J, Shen Z, Wu X, Wu M, Li Q, Qiu L, Yu N, Sferra TJ, Peng J.
    Cancer Res; 2019 May 01; 79(9):2257-2270. PubMed ID: 30862720
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J, Yang Q, Li J, Zhou S.
    Angiogenesis; 2014 Jan 01; 17(1):37-50. PubMed ID: 23907365
    [Abstract] [Full Text] [Related]

  • 14. Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene.
    Kong Y, Lu ZL, Wang JJ, Zhou R, Guo J, Liu J, Sun HL, Wang H, Song W, Yang J, Xu HX.
    Oncol Rep; 2016 Sep 01; 36(3):1447-56. PubMed ID: 27432230
    [Abstract] [Full Text] [Related]

  • 15. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
    Ghiasi N, Habibagahi M, Rosli R, Ghaderi A, Yusoff K, Hosseini A, Abdullah S, Jaberipour M.
    Asian Pac J Cancer Prev; 2014 Jan 01; 14(11):6605-11. PubMed ID: 24377575
    [Abstract] [Full Text] [Related]

  • 16. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R, Gupta G, Manohar M, Debnath U, Popli P, Prabhakar YS, Konwar R, Kumar S, Kumar A, Dwivedi A.
    Int J Biochem Cell Biol; 2016 Jan 01; 70():105-17. PubMed ID: 26556313
    [Abstract] [Full Text] [Related]

  • 17. The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.
    Raza S, Ohm JE, Dhasarathy A, Schommer J, Roche C, Hammer KD, Ghribi O.
    Mol Cell Biochem; 2015 Dec 01; 410(1-2):187-95. PubMed ID: 26350565
    [Abstract] [Full Text] [Related]

  • 18. Downregulated RRS1 inhibits invasion and metastasis of BT549 through RPL11‑c‑Myc‑SNAIL axis.
    Wang R, Peng C, Song J, Hua Y, Wu Q, Deng L, Cao Y, Zhang J, Zhang L, Wu L, Hou L.
    Int J Oncol; 2022 Mar 01; 60(3):. PubMed ID: 35179222
    [Abstract] [Full Text] [Related]

  • 19. Ribosome Biogenesis Regulator 1 Homolog (RRS1) Promotes Cisplatin Resistance by Regulating AEG-1 Abundance in Breast Cancer Cells.
    Song J, Peng C, Wang R, Hua Y, Wu Q, Deng L, Cao Y, Zhang L, Hou L.
    Molecules; 2023 Mar 25; 28(7):. PubMed ID: 37049702
    [Abstract] [Full Text] [Related]

  • 20. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
    Qin JJ, Wang W, Voruganti S, Wang H, Zhang WD, Zhang R.
    Oncotarget; 2015 Feb 20; 6(5):2623-40. PubMed ID: 25739118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.